CD4' T helper (Th) cells can be divided into two distinct subsets based on the pattern of cytokines that they produce on activation [l] . Thus T h l cells are characterized by their ability to secrete interleukin (1L)-2 and interferon y (IFNy ) , whereas T h 2 cells produce IL-4, IL-5 and IL-10. Some of these cytokines are thought to have important roles in the differentiation and function of mature T-cell subsets. In particular, IL-4 is necessary for the differentiation of T h 2 cells [2, 3] , and IL-12 is important for the generation of T h l cells [4, 5] . Indeed, the recent generation of IL-4-and IL-12-deficient mice [6-81 by gene targeting in embryonic stem cells has provided the most compelling evidence that these cytokines play a critical role in the differentiation of T h cell subsets.
Ultimately, the binding of cytokines to their receptors is thought to lead to biological responses by inducing the transcription of new gene programmes, and the recent identification of the JAK-STAT signalling pathway [9] has greatly increased our understanding of how this occurs at the molecular level. T h e results of a large number of studies have led to a paradigm of cytokine signalling whereby a novel class of cytoplasmic protein tyrosine kinases, the Janus kinases (JAKs), are activated in response to cytokine-receptor interactions. T h e next step in this pathway involves a family of latent transcription factors called signal transducers and activators of transcription (STAT). Current models of STAT activation suggest that STAT monomers in the cytoplasm become recruited to the cytokine receptor after its phosphorylation by JAKs, and dock to phosphotyrosine residues on the receptor via conserved SH2 domains. The STAT molecule is itself then phosphorylated, which results in its release from the receptor and concomitant dimerization [ 10-121. STAT dimers then translocate to the nucleus where they bind DNA and regulate transcription of target genes. Seven genes encoding members of the STAT family have been identified thus far, and IL-4 has been Abbreviations used: Th, T helper; IL, interleukin; IFN-y, interferon y ; JAK, Janus kinase; STAT, signal transducers and activators of transcriptin; IRS, insulin receptor substrate.
shown to activate Stat6 [10, 13, 14] , whereas IL-12 specifically activates Stat4 [ 15,161. T o determine the relative importance of the Stat6 signalling pathway in mediating the biological functions of IL-4, we [17] and others [18, 19] have recently generated Statbdeficient mice. Analysis of these animals has shown that a number of IL-Cmediated responses are impaired in the absence of Stat6. These include the up-regulation in the cell surface expression of inducible genes such as those encoding MHC class-I1 antigens, CD23, Thy-1 and the IL-4 receptor cr-chain. The production of IgE in response to immunization with anti-IgD or infection with Nippostrongylus brasiliensis is markedly impaired in Stat6-deficient mice, as is the proliferation of Statb-deficient lymphocytes in response to IL-4. Finally, Stat6-deficient T-cells fail to differentiate into ThZ cells in response to IL-4 in vitro. Indeed, essentially every known biological response induced by IL-4 examined thus far is impaired in cells from Stat6-deficient animals. These results were quite striking considering that stimulation of the IL-4 receptor has been shown to activate a second signalling pathway distinct from the JAK-STAT pathway. IL-4 stimulation of haematopoietic cells induces the phosphorylation of an insulin receptor substrate (IRS) termed 4PS or IRS-2 [20, 21] . Although activated IRS-2 associates with phosphatidylinositol 3-kinase, the role of this signalling pathway in mediating IL-4-induced responses is at present unclear.
Similarly, StatCdeficient mice have been generated to determine the role of this STAT molecule in mediating the effects of IL-12 [22, 23] . Here again, essentially every IL-12-induced response examined thus far is markedly impaired in cells from Stat4-deficient mice. Thus the ability of IL-12 to enhance production of IFN-y by, or induce the proliferation of, activated Stat4-deficient T-lymphocytes is completely abrogated. Moreover, IL-1 2-induced natural killer (NK) cell cytotoxicity is absent from cells from Stat4-deficient mice. Finally, Stat4-deficient T-cells are impaired in their ability to differentiate into T h l cells, in a similar way to that seen for the differentiation of Th2 cells from Statb-deficient mice. These results demonstrate that Stat4 and Stat6 are critical for mediating the effects of IL-12 and 1L-4 respectively.
Stat4-and Stat6-deficient mice are, at present, the best available mouse models to allow the study of immune responses dictated solely by T h l or T h 2 cells. Undoubtedly, these mice will be of great value in determining the role of individual T h cell subsets in a variety of immune phenomena such as tolerance, autoimmunity, and in the responses to parasitic infections and alloand xeno-geneic transplantation. However, it is interesting that, although Stat4-deficient lymphocytes are impaired in their ability to generate T h l cells, they demonstrate a propensity to produce ThZ-type cytokines, even under conditions that favour the development of T h l cells. Likewise, Stat6-deficient lymphocytes, although unable to differentiate into Th2 cells, demonstrate enhanced production of the T h l cytokine IFN-y , even under ThZ-skewing conditions. These results suggest that STATs play both positive and negative roles in controlling the differentiation of T h cell subsets. Given the importance in maintaining a proper balance of T h l and T h 2 cells in immune responses, it remains to be determined whether STAT molecules will be good therapeutic targets for the pharmacological manipulation of this balance.
